Sentences with phrase «sees fy»

Sees FY 2017 FFO per share $ 11.45 to $ 11.55.

* SEES FY CAPEX AT AROUND 8 BILLION EUROS, DOWN FROM 8.7 BILLION LAST YEAR Further company coverage: (Reporting by Milan newsroom)

Sees fy 2017 FFO per share $ 11.45 to $ 11.55.

We can look forward to seeing FY - 2014 results by March, at the latest — cash generation will be particularly interesting, with cash already comprising nearly 30 % of ZMNO's current market cap.

Not exact matches

«We still conservatively forecast no iPhone unit growth through FY 19 but see robust demand for other hardware offerings / wearables,» he noted.

Assuming these growth characteristics for FY 2016 and FY 2017, we see Apple's P / E of just 8x our FY 2015 forecast as both irrational and transient in nature, especially since many actively managed mutual funds remain underweight Apple in their portfolios.

Coca - Cola Amatil FY profits down 25 % as Australia bites Coca - Cola Amatil has said it is confident it will return to growth in the next few years after a poor performance in Australia saw profits in 2

Total support for basic research in FY 1998 would barely stay ahead of inflation at $ 15.3 billion (see Table 2), a 3.0 percent increase.

One challenge in this — and the problem for Democrats — is that in FY 2018, the most recent spending deal runs out, and spending is required by law to drop back to sequestration levels (see inflation - adjusted graph at right).

While not quite matching the Administration's full financial ambitions for the program, AFRI has nevertheless seen more than 50 percent budget growth since FY 2009.

Total support in FY 1999 would grow to $ 16.9 billion (see Table 2), a 7.7 percent increase.

In historical context, the Trump Administration would bring NSF's inflation - adjusted budget down to FY 2002 levels (see chart at right).

The AAAS analysis, Projected Effects of the President's FY 1998 Budget on Federal R&D (see Table 5), calculates the effects of the President's latest budget proposals on federal R&D during the period FY 1997 - 2002.

Neither High Energy Physics nor Nuclear Physics were given much detail in the omnibus package, but both would be subject to general reductions below FY 2016 levels in multiple areas, as can be seen in the table linked above.

The President's FY 1999 budget request would provide $ 77.7 billion for the federal investment in R&D, an increase of 2.2 percent or $ 1.7 billion above the current FY 1998 estimate (see Table 1).

[1] For a recent example, see the recent budget deal and the big R&D gains it facilitated in the FY 2018 omnibus.

NASA's Heliophysics Program would be flat - funded from FY 2017, whereas Astrophysics would see a total 8.9 percent increase to fund the Wide - Field Infrared Survey Telescope (WFIRST), among other missions.

On the science front, appropriators granted $ 698.2 million to the VA Medical & Prosthetic Research account, a 3.7 percent increase above FY 2017 levels, thus refuting the cuts sought by the Administration (see table; the Administration had also proposed an increase in research support dollars counted as R&D).

Under this scenario, discretionary spending (and thus, R&D) falls off a cliff in FY 2020, as is scheduled to happen under current law following expiration of the recent spending cap deal (see this link, especially the first graph).

See also: DOD, EPA, and USGS in the FY 2018 Budget USDA, NIST, and NOAA in the FY 2018 Budget DOE, NSF, and NASA in the FY 2018 Budget

Under the FY 2018 request, NIH also projects a success rate of 13.7 percent in FY 2018, the lowest funding rate since at least 1970 (see graph at right for recent years).

Biomedical Advanced Research and Development Authority (BARDA) BARDA and its Project BioShield initiative would see essentially no change from FY 2017 omnibus funding levels, with each funded at or just above $ 510 million.

This meant a return to the sequestration - level baseline in FY 2016, seen at right, with spending capped at just above $ 1 trillion in nominal dollars.

According to the latest AAAS estimates, both the House and Senate would provide moderate increases to federal R&D overall in FY 2017: the House would provide a $ 3.1 billion or 2.1 percent increase for R&D above FY 2016 levels, while the Senate would provide a $ 4.7 billion or 3.2 percent increase (see table).

In a letter to the community posted today, NSF Director Subra Suresh said «the major impact of sequestration will be seen in reductions to the number of new research grants and cooperative agreements awarded in FY 2013.

Therefore... we hope to see that the President's FY 2016 budget proposal prioritizes NIH funding so that the agency is able to begin the process of ensuring that our country is able to consistently support the plethora of research opportunities to improve public health that currently exist.

The bill also provides the House with mismatching authorizations and appropriations for the effected agencies in FY 2016, as shown in the chart below (see also this table).

While representing a 6.3 percent cut below FY 2016 levels, it's something of a departure in a year that sees climate programs at EPA, NOAA, and elsewhere slated for much larger cuts, especially given White House Budget Director Mick Mulvaney's belief that dollars spent on climate change are a waste of money.

(see funding table) NIH was the big winner in this year's omnibus, garnering a full $ 2 billion increase over FY 2015.

See U.S. Department of Education Fact Sheet, President Trump's FY 2018 Budget, available at https://www2.ed.gov/about/overview/budget/budget18/budget-factsheet.pdf (accessed April 5, 2018).

Mississippi was one of eight states to actually see a decrease in enrollment from FY 1992 through FY 2015.

This line totals $ 152.7 M in FY 2011 (see pg.

If you'd like to see how much we reduced FY 2010 consultant spending, you can see a summary and a full list of providers here.

The risk - sharing concept was recently referenced in a Senate HELP discussion paper (PDF) and in the President's FY 2019 budget proposal (PDF, see page 41).

We saw several of you asking us for investing in ELSS funds during late March, especially post-march 29th which made it impossible for investing in ELSS funds for FY 2018 - 19.

d) Can I also add PPI for FY12 - 13, FY13 - 14 & FY14 - 15, as i have seen my interest components for last 3 FYs have been more then 2lacs and this FY also it seems to be crossing 2 lac.

As regards earnings, they've essentially remained flat for the past 18 months — it's hard to see how management can now deliver against its 10 - 16 % earnings growth forecast for FY - 2014!?

Currently trading on 22.9 x FY - 2014 guidance (of $ 2.125), ICON looks fairly over-valued to me — but with US big pharma stocks generally back in favour, and the biotech sector on fire, it's no great surprise to see a high valuation here also.

Based on the step - up in FY - 2017 / 2018 revenue (per my estimates, see tables above), I propose Record's capable of earning a incremental 70 % operating profit margin — consistent with a relatively fixed cost base each year & an incentive scheme which awards employees 30 % of operating profits.

Since then, we've seen a v different H2 - 2013 performance — though noting the remarkable index result, the FY - 2013 outcome for the portfolios was actually somewhat predictable...

We should see Q4 / FY 2011 results released very shortly.

Noting this working capital outflow has essentially been reversed since (see Q1 / Q3 -2015 above), it's sensible to adjust accordingly — for example, if I substitute the adjusted operating margin of 7.6 % for FY - 2014, I re-calculate the average adjusted Op FCF margin to be 26.0 %.

Hopefully we'll see the same positive impact in Argo's FY P&L — but this will depend on whether the AREO payment's treated as genuine (current period) revenue, or as a settlement of outstanding receivables.

And the fact Saga now trades on 3.2 times peak earnings is a great reminder of the potential upside if we see sales regain / surpass their previous FY - 2013 peak in due course.

We'll see... I may post over the holidays, I may not, I'm not sure — but I look forward to assessing FY 2012 performance first thing in 2013, and then we'll take things from there!

Unfortunately, we still see negative operating free cash flow as the company continues to invest heavily in its platform (though it should turn positive on a FY basis)...

Assuming FY - 2013 stays in - line with the YTD (Q1 - Q3) trajectory we've seen, and using the table above, we now have seven years of data to work with.

This is also a pro-forma FY - 2018 — but it remains subject to AUME / fee / FX rate changes, etc. — this estimate's critical, as we see the full impact of the new AUME peak & sterling's post-Brexit vote collapse flow through... not only in terms of revenue, but a radically higher incremental operating margin.

Saga's adjusted operating profit margin has actually tripled vs. the 7.6 % margin we saw in FY - 2014.

FY 2017 showed AFFO / share growth of over 4 %, which is right in line with what I'd like to see from a business like this.